A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: procedure (650), etiquette (1), practice (609)

Chlorambucil_14day

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (14 day) There are several versions of this protocol each using a different dose or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14day.pdf

DA_3+8

Description
Regimen Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (3+8)–Cytarabine-Daunorubicin In-Patient Regimen • Acute Myeloid Leukaemia – InP-DA (3+8)–Cytarabine-Daun
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-8.pdf

DA_2+5

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (2 + 5) – Cytarabine-Daunorubicin In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-DA (2+5)–Cytarabine-D
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-2-5.pdf

CytarabineSC

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE SC Regimen • Acute Myeloid Leukaemia – Cytarabine SC Indication • Acute myeloid leukaemia in those 60 yea
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC.pdf

Cytarabine3000

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (3000mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (3000mg/m2) Indica
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine3000.pdf

AmsacrineCytarabineEtoposide_MACE

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Eto
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

Gemcitabine ver1

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER GEMCITABINE Regimen Ovarian – Gemcitabine Indication The treatment of advanced ovarian cancer WHO Performance status 0, 1, 2
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Gemcitabine-ver1.pdf

Cetuximab (7 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB (7 day) This regimen may require funding Regimen • Colorectal Cancer – Cetuximab (7 day) Indication • Metastatic colorectal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab7day.pdf

Everolimus Ver 1

Description
Chemotherapy Protocol PANCREATIC NEUROENDOCRINE CARCINOMA EVEROLIMUS This protocol may require funding Regimen PNET - Everolimus Indication The first or second line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Everolimus-Ver-1.pdf

Temozolomide (200)

Description
Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (200) Regimen • CNS – Temozolomide (200) Indication • Recurrent or progressive malignant glioblastoma multiforme in patients not
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-200.pdf
121 to 130 of 698
Previous … 11 12 13 14 15 … Next